Preventive and predictive testing
The lab platforms behind preventive health, assembled for the Asian market.
Preventive testing has moved well past ancestry novelty. Today a saliva kit, a single blood draw, or a stool sample can flag disease risk, screen for cancers before symptoms, profile your microbiome, and measure how fast you are aging. We already run the scientific platforms behind these tests. We put them together into one integrated offering, tuned for Asian populations, that you can deliver under your own brand.
Where research becomes product
This is where we turn R&D capability into products you can sell.
Most providers own one piece: a genotyping array, a sequencer, a single protein panel. We operate genomics and sequencing, proteomics and multiplex immunoassay, clinical labs, and bioinformatics and reporting under one roof. That means we can assemble a complete preventive-testing menu rather than resell a single test.
You pick the categories your patients or employees need. We run the science, validate it against Asian reference data where accuracy depends on it, and return branded reports. You offer a preventive-health line without building a lab.
The landscape
The preventive testing market, and where we run today.
Six categories now define direct-to-consumer and preventive testing worldwide. Each one reduces to a lab platform we already operate, so we can start you live today and build out the frontier with you.
Genetic (DNA) wellness testing
You send a saliva kit. We read the genome and return ancestry, trait, carrier, drug-response and disease-predisposition insight.
Blood biomarker panels
One blood draw profiles metabolic, cardiovascular, hormonal, nutrient and inflammatory markers against optimal ranges for proactive health.
Multiplex protein screening
We quantify tens to thousands of plasma proteins at once, from microlitre volumes, for risk stratification and disease-signature work.
Microbiome testing
We sequence the gut, oral or skin microbial community and turn it into diet, digestive and wellness insight, referenced to Asian baselines.
Multi-cancer early detection
A blood draw reads tumour-shed cell-free DNA to look for a shared cancer signal across many cancer types, before symptoms appear.
Biological age & multi-omics
We measure DNA methylation clocks and combine genomics, proteins, microbiome and metabolic data to track pace of aging over time.
Live today, Building and On the roadmap describe our current delivery stage per category. Ask us where any specific test stands before you plan a launch around it.
One group, four platforms
Preventive testing runs on a small set of platforms. We run all of them.
Every category above reduces to these four. That is why you can start with DNA wellness today and extend the same relationship into blood, microbiome, protein screening and biological age without ever changing supplier.
Genomics and sequencing
Genotyping arrays and next-generation sequencing power DNA wellness, microbiome (16S and shotgun), methylation-based biological-age clocks, and the cell-free DNA pipelines behind multi-cancer early detection.
Proteomics & multiplex immunoassay (PrimePlex)
Runs multiplex protein panels, quantifying many analytes from a small blood volume for biomarker and risk-signature work, and supports the protein components of advanced blood-based screening.
Clinical labs
Chemistry and immunoassay analysers deliver the comprehensive metabolic, lipid, hormonal, nutrient and inflammatory panels that anchor proactive health screening.
Bioinformatics and reporting
Turns raw genotyping, sequencing and biomarker data into scored, plain-language reports, applies cross-ancestry methods and Asian reference data, and produces the branded output your clinician or member reads.
A sample report
We translate the data into something a person can act on.
Whatever the test, the deliverable is the same: a colour-coded, plain-language report that a member and their clinician can read and use, weighted for Asian populations.
Report menu
Insight across the topics that matter.
Why Prima Nexus
Why partners build their preventive line with us.
Built for Asian populations
Most risk models and reference ranges were trained on European-ancestry data, and their accuracy drops in Asian populations. We weight interpretation toward Asian and Southeast Asian populations, so the insight you deliver fits the people in front of you.
The whole stack, one supplier
We run genomics, proteomics and multiplex immunoassay, clinical labs, and bioinformatics ourselves. Launch DNA wellness now and add blood panels, microbiome, protein screening or biological age later, without onboarding a new lab each time.
White-label by default
Reports carry your brand, not ours. Clinics, employers, hospitals and public-health programmes present an integrated preventive-testing line as their own.
No licence fees, pay per activation
You do not carry the cost of building or licensing a lab. You pay when a kit is activated, so the offering scales with your demand instead of your capital.
Non-invasive and multilingual
Self-collected samples, roughly 14 to 18 day turnaround, and reports in four languages weighted for Asian populations, built to fit real clinic and workplace workflows.
Product-ready, from our R&D
We commercialise research-grade capability into market-ready tests. You get a finished product to offer, not a science project to finish.
Who we serve
A managed service for the organisations that guide health.
Delivered as a white-label capability, so partners can offer preventive testing under their own brand, with no licence fees and no equipment to buy.
Genomic and preventive-testing results indicate risk and predisposition. They are not a diagnosis and do not confirm or rule out disease. They are intended to support proactive health decisions alongside a qualified healthcare professional, and never to replace clinical assessment, diagnosis or treatment.
Partner with Prima Nexus
Offer preventive testing under your own brand.
Tell us who you serve, patients, employees or a population-health programme, and which categories you want to lead with. We map them to our platforms and return a white-label offering you can put your name on.